课题基金 / 基金详情

Dissecting the mechanism of action of the renin angiotensin hormone angiotensin1-9

Dissecting the mechanism of action of the renin angiotensin hormone angiotensin1-9
剖析肾素血管紧张素激素 angiotensin1-9 的作用机制
批准号:
G0901161/1
负责人:
Stuart Nicklin
金额:
$48.87万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2010
资助国家:
英国
项目状态:
已结题
起止时间:
2010 至 --

项目摘要

项目成果

Stuart Nicklin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The body produces specific hormones which travel via the bloodstream and engage with receptors which contribute to the normal function of blood vessels, the heart and kidney. The main hormone from this system, angiotensin II, can become overactive and contribute to the development of cardiovascular disease, resulting in high blood pressure (hypertension) and finally enlargement of the heart and damage to kidneys. Although this has been known for a long time (in fact inhibitors of various facets of angiotensin II function are the target for a common group of drugs used to lower blood pressure in patients and treat conditions such as heart failure) the central mechanisms for the functioning of this hormone system are not completely understood. The hormone system has many different roles in the body depending upon the organ on which it acts. Also, new members of this hormone family are being discovered. Here we describe a role for a new hormone in this system, angiotensin 1-9. Angiotensin 1-9 was previously thought to be inactive but we have evidence to support it being an active hormone which inhibits angiotensin II actions. Thus angiotensin 1-9 may be an important therapeutic target in cardiovascular disease. We wish to full understand how this hormone functions and will achieve this using a range of techniques.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Angiotensin-(1-7) and angiotensin-(1-9): assessment as therapeutic targets in acute vascular injury and remodelling
  • 批准号:
    MR/L019108/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $45.61万
  • 财政年份:
    2014
  • 负责人:
    Stuart Nicklin
  • 依托单位:
Development of efficient disease-regulated expression cassettes for gene therapy using microRNA targeting sequences
  • 批准号:
    BB/F006667/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $42.99万
  • 财政年份:
    2008
  • 负责人:
    Stuart Nicklin
  • 依托单位:
国内基金
海外基金
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
  • 批准号:
    82371028
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵慧
  • 依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
  • 批准号:
    82372743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈卓佳
  • 依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
  • 批准号:
    82371054
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郭涛
  • 依托单位:
空气颗粒物通过调控白血病抑制因子参与影响IgA肾病进展的作用与机制研究
  • 批准号:
    82370711
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    谢静远
  • 依托单位: